Heidelberg Pharma Balance Sheet Health
Financial Health criteria checks 3/6
Heidelberg Pharma has a total shareholder equity of €45.1M and total debt of €5.1M, which brings its debt-to-equity ratio to 11.2%. Its total assets and total liabilities are €61.7M and €16.6M respectively.
Key information
11.2%
Debt to equity ratio
€5.07m
Debt
Interest coverage ratio | n/a |
Cash | €32.65m |
Equity | €45.11m |
Total liabilities | €16.55m |
Total assets | €61.67m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: HPHA's short term assets (€48.1M) exceed its short term liabilities (€16.5M).
Long Term Liabilities: HPHA's short term assets (€48.1M) exceed its long term liabilities (€69.8K).
Debt to Equity History and Analysis
Debt Level: HPHA has more cash than its total debt.
Reducing Debt: HPHA's debt to equity ratio has increased from 0% to 11.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HPHA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: HPHA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19.8% each year